Richette, Pascal

2016 updated EULAR evidence-based recommendations for the management of gout

Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases

Gout, Hyperuricemia, Uric AcidDrug-Induced Adverse Reactions

Cited by 1,681

Gout

Richette, P., & Bardin, T. (2010) · The Lancet

Gout, Hyperuricemia, Uric AcidInflammasome and immune disorders

Cited by 915

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 734

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery

Monoclonal and Polyclonal Antibodies ResearchDrug-Induced Adverse Reactions

Cited by 587

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance.

Grimaldi-Bensouda, L., Rossignol, M., Koné-Paut, I., Krivitzky, A., Lebrun-Frenay, C., Clet, J., Brassat, D., Papeix, C., Nicolino, M., Benhamou, P.-Y., et al. (2017) · Journal of Autoimmunity

Cervical Cancer and HPV ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 84